WALD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Waldencast PLC is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is in a transitional phase with mixed financial performance, bearish technical indicators, and no significant positive catalysts. It is better to wait for clearer signs of growth or stability before investing.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 1.024 with resistance at 1.147 and support at 0.901. Overall, the technical indicators suggest a weak trend without a clear buy signal.
The company's brands, Obagi and Milk, are considered strong and have growth potential. The upcoming Saypha injectables launch could provide upside in the future.
The company is undergoing a strategic review and has elevated costs related to an SEC investigation. Recent financial performance has been below expectations, with slower growth and missed revenue targets. Analysts have lowered price targets significantly.
In Q1 2025, revenue remained flat at $65.44M YoY. Net income and EPS also showed no improvement, with EPS at -1.51. Gross margin is strong at 69.91%, but overall financials indicate stagnation.
Analysts have lowered price targets significantly, with targets ranging from $2 to $2.50. While some maintain a Buy rating, they acknowledge the company's transitional phase and slower-than-expected growth. The stock valuation is seen as undervaluing brand strength, but the near-term outlook remains uncertain.
